Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mikael Dolsten Insider Profile
18 Followers
Mikael Dolsten, President R&D at Pfizer, holds 5.71K shares in Agilent (Ticker: A), holds 323.71K shares in Pfizer (Ticker: PFE), holds ― shares in Rocket Pharmaceuticals (Ticker: RCKT).
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
+1.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mikael Dolsten holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mikael Dolsten
Mikael Dolsten's Trading History
Pfizer
Feb 29, 2024
President R&D
Uninformative Sell
579.66K
$9.44M
Agilent
Mar 19, 2024
Director
Uninformative Buy
247.47K
$821.36K
Rocket Pharmaceuticals
―
Director
―
―
Karyopharm Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Mikael Dolsten's performance on stock
You May Also Like
Mikael Dolsten insider profile FAQ
What is the percentage of profitable transactions made by Mikael Dolsten?
The percentage of profitable transactions made by Mikael Dolsten is 40%.
What is the average return per transaction made by Mikael Dolsten?
The average return per transaction made by Mikael Dolsten is 1.10%.
What stocks does Mikael Dolsten hold?
Mikael Dolsten holds: PFE, A, RCKT, KPTI stocks.
What was Mikael Dolsten’s latest transaction?
Mikael Dolsten latest transaction was an Uninformative Buy of $247.47K.
What was Mikael Dolsten's most profitable transaction?
Mikael Dolsten’s most profitable transaction was an Informative Sell of PFE stock on May 12, 2022. The return on the trade was 23.10%.
What is Mikael Dolsten's role in Pfizer?
Mikael Dolsten's role in Pfizer is President R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.